Informed lands Patton to replace Case-bound CEO

Share this article:
Informed Medical Communications (IMC), a provider of interactive information services, has named Thomas Patton CEO.

Patton replaces Robert Goodman, who left to become president of content and commerce at AOL-founder Steve Case's start-up, Revolution Health Group.

“Business has grown substantially over the last few years,” Patton told MM&M. “We will continue to grow internally and we think there are acquisitions that can compliment our current product offering and specific vision to enhance the dialogue between physicians and patients.”

Patton most recently served as CEO of Wright Medical Technology, an orthopedic device company in Memphis, TN.

IMC has four divisions: The Peer Group provides interactive moderated peer groups and discussions for pharma clients; HealthTalk delivers patient education information through a variety of interactive channels; MRxHealth conducts research on the communication between physicians and patients; and RxDialogue conducts live and Web-based promotion for physicians.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...